A Case Report of Systemic Steroid Therapy for False Brain Tumors in Children

Authors

  • Dipjyoti Baishya
  • Utpal Kumar Misra

DOI:

https://doi.org/10.53469/jcmp.2024.06(10).30

Keywords:

uncontrolled longstanding headache, disc edema, CSF opening pressure, systemic steroids

Abstract

Study design: Case report. Purpose: to study the efficacy of systemic steroid in pediatric pseudotumor cerebri. Introduction: Pseudotumor cerebri is a condition caused by elevated intracranial pressure presenting most commonly with headache. It is a diagnosis of exculsion. Methods: A 15 year old girl presented in our OPD with headache since 3months, more in the posterior aspect, continuous type with severe intensity, non - radiating. On examination, her best corrected visual acuity in right eye was 6/9 and left eye was 6/6parts. She had normal anterior segment, normal IOP. Fundoscopy showed both optic discs edematous, pink in color with blurry disc margins, tortuous disc vessels, edematous peripapillary area. Rest of the retina was normal. Lumbar puncture showed elevated opening CSF pressure and normal CSF composition. Hence, she was diagnosed with IIH. She was started on oral prednisolone 1mg/kgbw once a day dosage, oral acetazolamide 250mg once a day, topical nepafenac 0.1% one drop thrice a day and timolol 0.5% eye drops twice a day. Discussion: The main goals of treatment are alleviation of symptoms, including headache, and preservation of vision. Steroids were commonly used for treating IIH in the past, but cause significant long - term side effects, such as weight gain, that are undesirable in IIH patients. Furthermore, withdrawal of steroids can cause rebound intracranial hypertension. Thus, steroids should not be used routinely for IIH treatment. Results: By the end of one month, patient was relieved of symptoms, best corrected visual acuity was 6/6 in both eyes with normal IOP, normal optic disc in both eyes. Conclusion: Steroids are an effective way of managing idiopathic intracranial hypertension in pediatric patients.

References

Wall M, George D. Idiopathic intracranial hypertension: a prospective study of 50 patients. Brain.1991; 114: 155–180.

Giuseffi V, Wall M, Siegel PZ, Rojas PB. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case - control study. N eurology.1991; 41: 239– 244.

Matthew J. Thurtell, Michael Wall. Idiopathic Intracranial Hypertension (Pseudotumor Cerebri): Recognition, Treatment, and Ongoing Management. Curr Treat Options Neurol.2013 February; 15 (1): 1–12.

Liu GT, Kay MD, Bienfang DC, Schatz NJ. Pseudotumor cerebri associated with corticosteroid withdrawal in inflammatory bowel disease. Am J Ophthalmol.1994; 117: 352–357.

Neville BG, Wilson J. Benign intracranial hypertension following corticosteroid withdrawal in childhood. BMJ.1970; 3 (5722): 554–556.

Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology.2007; 68: 229–232.

Liu GT, Glaser JS, Schatz NJ. High - dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol.1994; 118: 88– 96

Smith SV, Friedman DI. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes. Headache.2017 Sep; 57 (8): 1303 - 1310. doi: 10.1111/head.13144. Epub 2017 Jul 30. Erratum in: Headache.2018 Nov; 58 (10): 1697. PMID: 28758206.

Wall M, Johnson CA, Cello KE, et al.; for the NORDIC Idiopathic Intracranial Hypertension Study Group. Visual field outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest Ophthalmol Vis Sci.2016; 57: 805–812. DOI: 10.1167/iovs.15 - 18626

Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol.2014 Jun; 71 (6): 693 - 701. doi: 10.1001/jamaneurol.2014.133. PMID: 24756302; PMCID: PMC4351808.

Mollan SP, Davies B, Silver NC, et al. J Neurol Neurosurg Psychiatry 2018; 89: 1088–1100.

Markey KA, Mollan SP, Jensen RH, et al. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol 2016; 15: 78–91.

Spitze A, Malik A, Al - Zubidi N, et al. Optic nerve sheath fenestration vs cerebrospinal diversion procedures: what is the preferred surgical procedure for the treatment of idiopathic intracranial hypertension failing maximum medical therapy? J Neuroophthalmol 2013; 33: 183–8.

Degnan AJ, Levy LM. Pseudotumor cerebri: brief review of clinical syndrome and imaging findings.

AJNR Am J Neuroradiol 2011; 32: 1986–93

Yri HM, Rönnbäck C, Wegener M, et al. The course of headache in idiopathic intracranial hypertension: a 12 - month prospective follow - up study. Eur J Neurol 2014; 21: 1458–64

Downloads

Published

2024-10-29

How to Cite

Baishya, D., & Misra, U. K. (2024). A Case Report of Systemic Steroid Therapy for False Brain Tumors in Children. Journal of Contemporary Medical Practice, 6(10), 147–148. https://doi.org/10.53469/jcmp.2024.06(10).30